Patents by Inventor Gilran Kim

Gilran Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12173210
    Abstract: A solventlesss quantum dot composition, a method for preparing the same, and a cured film, a color filter, and a display device including the same are disclosed. The solventless quantum dot composition comprises quantum dots surface-modified with at least two ligands, has low viscosity and good optical properties, and can be prepared by synthesis of quantum dots (QDs), followed by direct ligand substitution in the solution, thereby securing a simplified preparation process.
    Type: Grant
    Filed: September 19, 2022
    Date of Patent: December 24, 2024
    Assignees: HANSOL CHEMICAL CO.,LTD, SAMSUNG DISPLAY CO., LTD.
    Inventors: Gilran Kim, Yunju Bae, Ahyoung Jo, Shulgi Park, Eunhee Nam, Sungmin Ha, Chunrae Nam, Sunyoung Kwon, Buyong Kim, Jinwon Kim, Hye-Jin Paek, Taeyoung Song
  • Publication number: 20240336797
    Abstract: A quantum dot composition including quantum dots, a photopolymerizable monomer, and an oligomer, wherein the oligomer includes a compound containing a carbon-carbon double bond and a compound containing a thiol group.
    Type: Application
    Filed: March 28, 2024
    Publication date: October 10, 2024
    Inventors: Sungjun KOH, Daehee LEE, Ilju MUN, Kyoungmo NAM, Hyunjin KANG, Gilran KIM, Sungmin YOO, Wonseok YU, Mihee YUN, Euyjin LEE
  • Publication number: 20240287382
    Abstract: A solventlesss quantum dot composition, a method for preparing the same, and a cured film, a color filter, and a display device including the same are disclosed. The solventless quantum dot composition comprises quantum dots surface-modified with at least two ligands, has low viscosity and good optical properties, and can be prepared by synthesis of quantum dots (QDs), followed by direct ligand substitution in the solution, thereby securing a simplified preparation process.
    Type: Application
    Filed: September 19, 2022
    Publication date: August 29, 2024
    Inventors: Gilran KIM, Yunju BAE, Ahyoung JO, Shulgi PARK, Eunhee NAM, Sungmin HA, Chunrae NAM, Sunyoung KWON, Buyong KIM, Jinwon KIM, Hye-Jin PAEK, Taeyoung SONG
  • Publication number: 20240166687
    Abstract: The present disclosure relates to a composition for preventing or treating autoimmune disease, which is based on a CTLA4-derived, regulatory T cell-inducing peptide. The composition has an excellent effect of inhibiting differentiation into cytotoxic Th17 cells that produce and secrete inflammatory cytokines and increasing differentiation into regulatory T cells (Treg) and, thus, can be advantageously utilized as a pharmaceutical composition that can prevent or treat autoimmune disease caused by regulatory anomalies of various immune responses.
    Type: Application
    Filed: March 31, 2022
    Publication date: May 23, 2024
    Applicant: IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY)
    Inventors: Je-Min CHOI, Gilran KIM
  • Publication number: 20240101848
    Abstract: A quantum dot composition, a preparation method therefor, and a cured film, a color filter and a display device that comprise the same are described. Specifically, a solventless quantum dot composition comprises quantum dots, which are surface-treated with two types of ligands. As a result, the quantum dot composition exhibits low viscosity, excellent optical properties, and high storage stability.
    Type: Application
    Filed: June 3, 2021
    Publication date: March 28, 2024
    Inventors: Yunju Bae, Gilran Kim, Ahyoung Jo, Hyunjin Kang, Kyeonghun Gil, Shulgi Park, Eunhee Nam, Sungmin Ha, Chunrae Nam, Sunyoung Kwon, Hye-Jin Paek, Keunchan Oh, Hyeokjin Lee